Risk, choice and the 'girl vaccine': Unpacking human papillomavirus (HPV) immunisation

Health, Risk and Society

Volumn 14, Issue 1, 2012, Pages 57-69

  Mishra, Amrita ^a   Graham, Janice E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

choice; gender; heteronormative; human papillomavirus; risk; vaccine

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANADA; CANCER RISK; HEALTH PROMOTION; HUMAN; IMMUNIZATION; RISK FACTOR; SEXUAL ORIENTATION; SEXUALITY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 84860801842     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698575.2011.641524     Document Type: Article

References (67)

1. Alaszewski, A. M. and Brown, P. R. 2007. Risk, uncertainty and knowledge. Health, Risk and Society, 9(1): 1-10.
2. Aronowitz, R. 2010. "Gardasil: a vaccine against cancer and a drug to reduce risk". In Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions, Edited by: Wailoo, K. 21-38. Baltimore, Maryland: Johns Hopkins University Press.
3. Braun, L. and Phoun, L. 2010. "HPV vaccination campaigns: Masking uncertainty, erasing complexity". In Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions, Edited by: Wailoo, K. 39-60. Baltimore, Maryland: Johns Hopkins University Press.
4. Bush, J. 2000. 'It's just part of being a woman': Cervical screening, the body and femininity. Social Science and Medicine, 50(3): 429-444.
5. Butler, J. 1990. Gender trouble: Feminism and the subversion of identity, New York: Routledge.
6. Cason, J. and Mant, C. A. 2005. High-risk mucosal human papillomavirus infections during infancy and childhood. Journal of Clinical Virology, 32(SUPPL. 1): 52-58.
7. Centers for Disease Control and Prevention (CDC). 2010a. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(20): 630-632.
8. Centers for Disease Control and Prevention (CDC). 2010b. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(36): 626-629.
9. Clarke, A. E. 2003. Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine. American Sociological Review, 68(2): 161-194.
10. Colgrove, J. 2006. The ethics and politics of compulsory HPV vaccination. The New England Journal of Medicine, 355(23): 2389-2391.
11. Colgrove, J., Abiola, S. and Mello, M. M. 2010. HPV vaccination mandates-Lawmaking amid political and scientific controversy. New England Journal of Medicine, 363(8): 785-791.
12. Comeau, P. 2007. Debate begins over public funding for HPV vaccine. Canadian Medical Association Journal, 176(7): 913
13. Crosbie, E. J. and Brabin, L. 2010. Cervical cancer: Problem solved? Vaccinating girls against human papillomavirus. BJOG: An International Journal of Obstetrics and Gynaecology, 117(2): 137-142.
14. Cutts, F. T. 2007. Human papillomavirus and HPV vaccines: A review. Bulletin-World Health Organization, 85(9): 719-726.
15. Dickerson, J. B., Smith, M. L. and Ory, M. G. 2011. Increasing uptake of Gardasil among American adolescents: Comparisons with the history of hepatitis B vaccination. Human Vaccines, 7(2): 211-219.
16. Douglas, M. 1992. Risk and blame: Essays in cultural theory, London: Routledge.
17. Douglas, M. 2004. Purity and danger: An analysis of concept of pollution and taboo, London: Routledge.
18. Epstein, S. 2010. "The great undiscussable: HPV, anal cancer and gay men's health". In Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions, Edited by: Wailoo, K. 61-90. Baltimore, Maryland: Johns Hopkins University Press.
19. Foucault, M. 1995. Discipline and punish: The birth of the prison, New York: Vintage Books.
20. Foucault, M. 1998. The history of sexuality, vol.1: The will to knowledge, London: Penguin.
21. Foucault, M. and Faubion, J. D. 2000. Power, New York: New Press.
22. Forster, A., Wardle, J., Waller, J. and Stephenson, J. 2010. Passport to promiscuity or lifesaver: Press coverage of HPV vaccination and risky sexual behavior. Journal of Health Communication, 15(2): 205-217.
23. Franco, E. L. and Harper, D. M. 2005. Vaccination against human papillomavirus infection: A new paradigm in cervical cancer control. Vaccine, 23(17-18): 2388-2394.
24. Frazer, I. 2010. "Human Papillomaviruses". In Vaccines: A biography, Edited by: Artenstein, A. W. 361-373. New York: Springer.
25. Gabriel, T. and Grady, D. 2011. In republican race, a heated battle over the HPV vaccine [online]. New York Times, 14 Sept Available from: http://www.nytimes.com/2011/09/14/us/politics/republican-candidates-battle-over-hpv-vaccine.html?_r=2&ref=health# [Accessed 14 September 2011]
26. Gennep, A. V. 2007. The rites of passage, Chicago: The University of Chicago Press.
27. Government of Nova Scotia. 2007. HPV immunization launched [online] June 20. Available from: http://www.gov.ns.ca/news/details.asp?id=20070620002 [Accessed 22 August 2011]
28. Government of Quebec, Ministère de la Santé et des Services sociaux. 2011. How to protect your daughter against HPV; Vaccine or chastity belt? [online] Available from: http://www.vaccinvph.gouv.qc.ca/assets/vaccineorchastitybelt.pdf [Accessed 30 August 2011]
29. Griffiths, F. 2010. Screening for breast cancer: Medicalization, visualization and the embodied experience. Health, 14(6): 653-668.
30. Gulli, C. 2007. Our girls are not guinea pigs: is an upcoming mass inoculation of a generation unnecessary and potentially dangerous? [online]. Macleans, 27 August Available from: http://www.macleans.ca/science/health/article.jsp?content=20070827_108312_108312&page=1 [Accessed 22 August 2011]
31. Haas, M. 2009. Drugs, sex, money and power: An HPV vaccine case study. Health Policy, 92(2-3): 288-295.
32. Haber, G., Marlow, R. M. and Zimet, G. D. 2007. The HPV vaccine mandate controversy. Journal of Pediatric and Adolescent Gynecology, 20(6): 325-331.
33. Heffernan, M. E., Garland, S. M. and Kane, M. A. 2010. Global reduction of cervical cancer with human papillomavirus vaccines: Insights from the hepatitis B virus vaccine experience. Sexual Health, 7(3): 383-390.
34. Hekman, S. J. 1996. Feminist interpretations of Michel Foucault, University Park, PA: Pennsylvania State University Press.
35. Hernandez, G. and Nestor, C. 2006. Educating teens about vaccines. Journal of Pediatric Health Care, 20(5): 342-349.
36. Howson, A. 1999. Cervical screening, compliance and moral obligation. Sociology of Health and Illness, 21(4): 401-425.
37. Howson, A. 2001. Locating uncertainties in cervical screening. Health, Risk and Society, 3(2): 167-179.
38. Kane, M. A. 2010. Global implementation of human papillomavirus (HPV) vaccine: Lessons from hepatitis B vaccine. Gynecologic Oncology, 117(2 SUPPL.): S32-S35.
39. Koulova, A. 2008. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine, 26(51): 6529-6541.
40. Lévy-Bruhl, D. 2009. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey. European Journal of Cancer, 45(15): 2709-2713.
41. Lippman, A. 2007. Human papillomavirus, vaccines and women's health: Questions and cautions. Canadian Medical Association Journal, 177(5): 484-487.
42. Locock, L. and Alexander, J. 2006. 'Just a bystander'? Men's place in the process of fetal screening and diagnosis. Social Science and Medicine, 62(6): 1349-1359.
43. Lupton, D. 1993. Risk as moral danger: The social and political functions of risk discourse in public health. International Journal of Health Services, 23(3): 425-435.
44. Lupton, D. 1999. Risk, London: Routledge.
45. Mah, C. L. 2009. Governing Immunization in Canada, 138-156. Thesis (PhD). University of Toronto. Available from: https://tspace.library.utoronto.ca/bitstream/1807/19058/1/Mah_Catherine_L_200911_PhD_thesis.pdf [Accessed 22 August 2011]
46. Mackroth, M. S. 2010. Immunizing school-age children and adolescents: Experience from low- and middle-income countries. Vaccine, 28(5): 1138-1147.
47. Mamo, L. and Fosket, J. R. 2009. Scripting the body: Pharmaceuticals and the (re)making of menstruation. Signs, 34(4): 925-949.
48. Markowitz, L. E. 2007. Quadrivalent Human Papillomavirus Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report: Recommendations and Reports, 56(RR-2): 1-24.
49. Martin, E. 1988. Medical metaphors of women's bodies: menstruation and menopause. International Journal of Health Services, 18(2): 237-254.
50. Martin, E. 2001. The woman in the body a cultural analysis of reproduction, Boston: Beacon Press.
51. McKay, B. 2011. Panel urges HPV vaccine for boys [online]. Wall Street Journal, 26 Oct http://online.wsj.com/article/SB10001424052970204777904576653120787003308.html [Accessed 26 October 2011]
52. McKie, L. 1995. The art of surveillance or reasonable prevention? The case of cervical screening. Sociology of Health and Illness, 17(4): 441-457.
53. Munira, S. L. and Fritzen, S. A. 2007. What influences government adoption of vaccines in developing countries? A policy process analysis. Social Science and Medicine, 65(8): 1751-1764.
54. Muñoz, N. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer, 111(2): 278-285.
55. National Advisory Committee on Immunization (NACI). 2007. Statement on Human Papillomavirus vaccine [online] Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07pdf/acs33-02.pdf [Accessed 22 August 2011]
56. Petts, J. and Niemeyer, S. 2004. Health risk communication and amplification: learning from the MMR vaccination controversy. Health, Risk & Society, 6(1): 7-23.
57. Ramazanoglu, C. 1993. Up against Foucault: explorations of some tensions between Foucault and feminism, London: Routledge.
58. Reventlow, S. D., Hvas, L. and Malterud, K. 2006. Making the invisible body visible. Bone scans, osteoporosis and women's bodily experiences. Social Science and Medicine, 62(11): 2720-2731.
59. Rothman, S. M. and Rothman, D. J. 2009. Marketing HPV vaccine: Implications for adolescent health and medical professionalism. JAMA-Journal of the American Medical Association, 302(7): 781-786.
60. Scheifele, D. 1998. Universal childhood hepatitis B vaccination: infants vs. preadolescents, the Canadian perspective. The Pediatric Infectious Disease Journal, 17(7 SUPPL.): 35-37.
61. Scheifele, D. W. 2007. The challenges facing Canadian trialists in an increasingly competitive global market: what can be done to remain competitive?. Canadian Journal of Infectious Diseases and Medical Microbiology, 18(3): 205-215.
62. Steenbeek, A. 2011. Ill-informed consent? A content analysis of physical risk disclosure in school-based HPV vaccine programs. Public Health Nursing, [online; pre-inclusion in issue] DOI: 10.1111/j.1525-1446.2011.00974.x [Accessed 31 October 2011]
63. Stöckl, A. 2010. "Public discourses and policy making: the HPV vaccination from the European perspective". In Three shots at prevention: the HPV vaccine and the politics of medicine's simple solutions, Edited by: Wailoo, K. 254-269. Baltimore, Maryland: Johns Hopkins University Press.
64. Wailoo, K. 2010. "Vaccine timelines". In Three shots at prevention: the HPV vaccine and the politics of medicine's simple solutions, Edited by: Wailoo, K. xix-xxx. Baltimore, Maryland: Johns Hopkins University Press.
65. Watson, J. 1996. Lay theorizing about'the body' and implications for health promotion. Health Education Research, 11(2): 161-172.
66. Watson, M. 2009. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Australian and New Zealand Journal of Public Health, 33(4): 365-370.
67. Wieser, B. and Karner, S. 2006. "Individualizing decisions: on the paradoxes of prenatal testing". In Prenatal testing: individual decision or distributed action?, Edited by: Wieser, B., Karner, S. and Berger, W. 27-52. Munich/Vienna: Profil.